EW Edwards Lifesciences
NYSE · SEC CIK 1099800 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $27.68M 42 sales by 9 insiders
- Filings on record
- 445 since 2021-07-01, latest 2026-09-14 18:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| Zovighian Bernard J | CEO, Dir | — | $7.00M |
| Ullem Scott B. | CFO, CVP | — | $3.87M |
| Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| Bruls Annette | CVP, EMEACLA | — | $237.9K |
| STONE HEISZ LESLIE | Dir | — | $218.1K |
| Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| Davis Leslie C. | Dir | — | — |
Transactions 820
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-08 | 2022-04-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.7K | +20% | +$240.4K |
| D | 2022-04-08 | 2022-04-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $35.20 | +3,675 | 101.9K | +4% | +$129.4K |
| D | 2022-04-08 | 2022-04-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $123.07 | -3,675 | 98.2K | -4% | -$452.3K |
| DM | 2022-04-05 | 2022-04-05 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $121.03 | -7,242 | 197.6K | -4% | -$876.5K |
| D | 2022-04-05 | 2022-04-05 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $36.75 | +7,242 | 204.9K | +4% | +$266.1K |
| DM | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $112.36 | -32.5K | 79.3K | -29% | -$3.66M |
| D | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 124.3K | +57% | +$980.3K |
| DI | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.38M | +0.4% | $0 |
| D | 2022-03-22 | 2022-03-22 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 102.2K | -11% | $0 |
| DM | 2022-03-14 | 2022-03-14 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $104.65 | -20.0K | 27.4K | -42% | -$2.09M |
| D | 2022-03-14 | 2022-03-14 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.4K | +73% | +$435.2K |
| DM | 2022-03-11 | 2022-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $106.01 | -11.7K | 158.6K | -7% | -$1.24M |
| D | 2022-03-11 | 2022-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +11.7K | 163.8K | +8% | +$253.7K |
| DM | 2022-03-11 | 2022-03-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $106.00 | -11.1K | 62.3K | -15% | -$1.17M |
| D | 2022-03-11 | 2022-03-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| D | 2022-03-08 | 2022-03-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $107.60 | -3,675 | 98.0K | -4% | -$395.4K |
| D | 2022-03-08 | 2022-03-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $35.20 | +3,675 | 101.7K | +4% | +$129.4K |
| DM | 2022-03-08 | 2022-03-08 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $106.62 | -7,242 | 201.0K | -3% | -$772.2K |
| D | 2022-03-08 | 2022-03-08 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $36.75 | +7,242 | 204.7K | +4% | +$266.1K |
| 2022-02-22 | 2022-02-21 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $105.62 | -319 | 36.8K | -0.9% | -$33.7K | |
| D | 2022-02-18 | 2022-02-18 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +20.0K | 47.4K | +73% | +$435.2K |
| DM | 2022-02-18 | 2022-02-18 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $106.32 | -20.0K | 40.5K | -33% | -$2.13M |
| DM | 2022-02-15 | 2022-02-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $110.09 | -32.5K | 117.5K | -22% | -$3.58M |
| D | 2022-02-15 | 2022-02-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 105.0K | -11% | $0 |
| D | 2022-02-15 | 2022-02-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 124.3K | +57% | +$980.3K |
| DI | 2022-02-15 | 2022-02-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.37M | +0.4% | $0 |
| DM | 2022-02-11 | 2022-02-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $111.49 | -11.1K | 67.0K | -14% | -$1.23M |
| DI | 2022-02-11 | 2021-08-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | G - Gift | $0.00 | -7,000 | 117.3K | -6% | $0 |
| D | 2022-02-11 | 2022-02-11 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| D | 2022-02-08 | 2022-02-08 | EW | GALLAHUE KIERAN | Dir | S - Sale+OE | $110.79 | -32.3K | 3,433 | -90% | -$3.57M |
| D | 2022-02-08 | 2022-02-08 | EW | GALLAHUE KIERAN | Dir | M - OptEx | $22.29 | +32.3K | 35.7K | +940% | +$719.0K |
| DM | 2022-02-08 | 2022-02-08 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $109.55 | -4,386 | 201.5K | -2% | -$480.5K |
| D | 2022-02-08 | 2022-02-08 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $36.75 | +4,386 | 201.8K | +2% | +$161.2K |
| D | 2022-02-08 | 2022-02-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| D | 2022-02-08 | 2022-02-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $110.20 | -6,350 | 98.0K | -6% | -$699.8K |
| DM | 2022-01-31 | 2022-01-28 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $101.15 | -11.1K | 61.5K | -15% | -$1.12M |
| D | 2022-01-31 | 2022-01-28 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 68.4K | +19% | +$240.4K |
| D | 2022-01-31 | 2021-12-22 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | G - Gift | $0.00 | +1,000 | 57.4K | +2% | $0 |
| D | 2022-01-14 | 2022-01-14 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| DM | 2022-01-14 | 2022-01-14 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $119.53 | -10.0K | 36.3K | -22% | -$1.20M |
| D | 2022-01-07 | 2022-01-06 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 233.1K | +24% | +$980.3K |
| DI | 2022-01-07 | 2022-01-06 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.25M | +0.4% | $0 |
| DM | 2022-01-07 | 2022-01-06 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $123.88 | -32.5K | 207.7K | -14% | -$4.03M |
| D | 2022-01-07 | 2022-01-06 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 220.3K | -5% | $0 |
| D | 2022-01-07 | 2022-01-07 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| D | 2022-01-07 | 2022-01-07 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $122.16 | -6,350 | 98.0K | -6% | -$775.7K |
| DM | 2021-12-20 | 2021-12-20 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $119.12 | -32.5K | 226.5K | -13% | -$3.88M |
| D | 2021-12-20 | 2021-12-20 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 214.0K | -6% | $0 |
| D | 2021-12-20 | 2021-12-20 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 233.1K | +24% | +$980.3K |
| DI | 2021-12-20 | 2021-12-20 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.24M | +0.4% | $0 |
| D | 2021-12-17 | 2021-12-17 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| D | 2021-12-17 | 2021-12-17 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $121.24 | -10.0K | 27.4K | -27% | -$1.21M |
| D | 2021-12-10 | 2021-12-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| DM | 2021-12-10 | 2021-12-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $121.50 | -11.1K | 56.4K | -16% | -$1.34M |
| D | 2021-12-10 | 2021-12-10 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $121.49 | -7,830 | 197.4K | -4% | -$951.3K |
| D | 2021-12-10 | 2021-12-10 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $35.20 | +7,830 | 205.3K | +4% | +$275.6K |
| D | 2021-12-10 | 2021-12-10 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| DM | 2021-12-10 | 2021-12-10 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $121.50 | -6,350 | 104.0K | -6% | -$771.5K |
| D | 2021-11-29 | 2021-11-29 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | S - Sale+OE | $110.58 | -100 | 152.1K | -0.1% | -$11.1K |
| D | 2021-11-29 | 2021-11-29 | EW | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | M - OptEx | $21.76 | +100 | 152.2K | +0.1% | +$2,176 |
| 2021-11-24 | 2021-11-24 | EW | VALERIANI NICHOLAS J | Dir | P - Purchase | $112.23 | +1,500 | 63.8K | +2% | +$168.3K | |
| D | 2021-11-19 | 2021-11-18 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +10.0K | 37.4K | +36% | +$217.6K |
| DM | 2021-11-19 | 2021-11-18 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $117.79 | -10.0K | 27.4K | -27% | -$1.18M |
| D | 2021-11-10 | 2021-11-10 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $35.20 | +7,830 | 380.0K | +2% | +$275.6K |
| D | 2021-11-10 | 2021-11-10 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $119.79 | -7,830 | 372.1K | -2% | -$938.0K |
| D | 2021-11-09 | 2021-11-09 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 233.1K | +24% | +$980.3K |
| D | 2021-11-09 | 2021-11-09 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 220.6K | -5% | $0 |
| DI | 2021-11-09 | 2021-11-09 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.22M | +0.4% | $0 |
| DM | 2021-11-09 | 2021-11-09 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $119.90 | -32.5K | 206.4K | -14% | -$3.90M |
| D | 2021-11-08 | 2021-11-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $119.40 | -6,350 | 98.0K | -6% | -$758.2K |
| D | 2021-11-08 | 2021-11-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| D | 2021-11-05 | 2021-11-05 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| DM | 2021-11-05 | 2021-11-05 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $117.17 | -11.1K | 56.4K | -16% | -$1.29M |
| D | 2021-10-18 | 2021-10-18 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +9,741 | 37.2K | +36% | +$212.0K |
| DM | 2021-10-18 | 2021-10-18 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $110.41 | -9,741 | 34.6K | -22% | -$1.08M |
| D | 2021-10-12 | 2021-10-11 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $35.20 | +7,830 | 380.0K | +2% | +$275.6K |
| D | 2021-10-12 | 2021-10-11 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $108.00 | -7,830 | 372.1K | -2% | -$845.6K |
| D | 2021-10-08 | 2021-10-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| D | 2021-10-08 | 2021-10-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $110.91 | -6,350 | 98.0K | -6% | -$704.3K |
| DM | 2021-10-08 | 2021-10-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $110.49 | -11.1K | 67.3K | -14% | -$1.22M |
| D | 2021-10-08 | 2021-10-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| D | 2021-10-01 | 2021-10-01 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 233.1K | +24% | +$980.3K |
| DM | 2021-10-01 | 2021-10-01 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $111.72 | -32.5K | 188.0K | -15% | -$3.64M |
| DI | 2021-10-01 | 2021-10-01 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.21M | +0.4% | $0 |
| D | 2021-10-01 | 2021-10-01 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 220.3K | -5% | $0 |
| D | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | M - OptEx | $21.76 | +45.0K | 233.1K | +24% | +$980.3K |
| DM | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | S - Sale+OE | $121.17 | -32.5K | 188.0K | -15% | -$3.94M |
| D | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | -12.5K | 215.6K | -5% | $0 |
| DI | 2021-09-16 | 2021-09-15 | EW | MUSSALLEM MICHAEL A | COB, CEO, Dir | G - Gift | $0.00 | +12.5K | 3.20M | +0.4% | $0 |
| D | 2021-09-10 | 2021-09-10 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $122.59 | -7,830 | 372.1K | -2% | -$959.9K |
| D | 2021-09-10 | 2021-09-10 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $35.20 | +7,830 | 380.0K | +2% | +$275.6K |
| DM | 2021-09-10 | 2021-09-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $122.26 | -11.1K | 67.1K | -14% | -$1.35M |
| D | 2021-09-10 | 2021-09-10 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $21.76 | +11.1K | 67.4K | +20% | +$240.4K |
| D | 2021-09-08 | 2021-09-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
| D | 2021-09-08 | 2021-09-08 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | S - Sale+OE | $121.25 | -6,350 | 98.0K | -6% | -$769.9K |
| D | 2021-09-08 | 2021-09-08 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $21.76 | +9,741 | 37.2K | +36% | +$212.0K |
| D | 2021-09-08 | 2021-09-08 | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $121.28 | -9,741 | 27.4K | -26% | -$1.18M |
| D | 2021-08-10 | 2021-08-10 | EW | Wood Larry L | CVP, TAVR | M - OptEx | $35.20 | +7,830 | 380.0K | +2% | +$275.6K |
| D | 2021-08-10 | 2021-08-10 | EW | Wood Larry L | CVP, TAVR | S - Sale+OE | $114.14 | -7,830 | 372.1K | -2% | -$893.7K |
| D | 2021-08-09 | 2021-08-09 | EW | WANG HUIMIN | CVP, Japan, Intercontinental | M - OptEx | $21.76 | +6,350 | 104.4K | +6% | +$138.2K |
Purchase Sale Sale after option exercise All abbreviations